Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2008-08-15
2010-06-08
Badio, Barbara P (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
C514S178000, C514S179000, C552S502000, C552S625000, C568S326000
Reexamination Certificate
active
07732493
ABSTRACT:
The invention relates to new 2-substituted D-homo-estra-1,3,5(10)-trienes of general formula Iin whichR2means a C1-C8-alkyl group, a C1-C8-alkyloxy group or a halogen atom,R13means a hydrogen atom or a methyl group,R17means a hydrogen atom or a fluorine atom,as well as their pharmaceutically acceptable salts,their manufacture and use as medicaments for prophylaxis and therapy of estrogen-dependent diseases that can be influenced by inhibition of 17β-hydroxy steroid dehydro-genase type 1.
REFERENCES:
patent: 3005835 (1961-10-01), Johns
patent: 5512558 (1996-04-01), Enhsen et al.
patent: 6541463 (2003-04-01), Labrie et al.
patent: 2005/0031651 (2005-02-01), Gervais et al.
patent: 10307103 (2003-02-01), None
patent: WO 87/00427 (1987-01-01), None
patent: WO 03/017973 (2003-03-01), None
patent: WO 2004/074309 (2004-09-01), None
Egorova, V. V. et al., “Structure and reactivity of steroids. VI. Long range effects in estra—1,3,5-(10)-triene compounds,” Tetrahedron, 1973, pp. 301-307 CODEN: TETRAB, vol. 29, No. 2, XP002350863.
Eliseev et al., “Synthesis of steroid estrogens 8-isoanalogs with a substituent at C-2.” Vestnik Leningradskogo Universiteta, Seriya 4: Fizika, Khimiya, No. 4, pp. 74-79, 1991. English Abstract.
Zakharova et al., “Antioxidant properties of some steroids.” Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, No. 3, pp. 456-465, 1996. English Abstract.
Eliseev et al., “Synthesis of racemic 2-methyl-D-homo-8-isoestrone.” Zhurmal Obshchei Khimii, vol. 57(4), 964-966, 1987, English Abstract.
Adamski Jerzy
Deluca Dominga
Elger Walter
Gege Christian
Hillisch Alexander
Badio Barbara P
Bayer Schering Pharma Aktiengesellschaft
Millen White Zelano & Branigan P.C.
LandOfFree
2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4234201